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Purpose: To identify comorbidities associated with increased rates of functional decline in persons with lower-extremity
peripheral arterial disease (PAD). We also determined whether female sex and black race were associated with greater
functional decline than male sex and white race, respectively, in PAD.
Methods: Three-hundred ninety-seven men and women with PADwere followed prospectively for a median of 36 months.
The presence of comorbid illnesses was determined with medical record review, patient report, medications, laboratory
values, and a primary care physician questionnaire. Functional outcomes, measured annually, included the 6-minute walk,
usual-paced and fast-paced 4-meter walking speed, and summary performance score. The summary performance score is
a composite measure of lower-extremity functioning (score range, 0 to 12; 12  best).
Results: Adjusting for known and potential confounders, PAD patients with pulmonary disease had a significantly greater
average annual decline in 6-minute walk performance of 34.02 ft/y (95% confidence interval [CI], 60.42 to 7.63;
P  .012), rapid-paced 4-meter walk speed of 0.028 m/s/y (95% CI, 0.054 to 0.001; P  .042), and summary
performance score of0.460/y (95%CI,0.762 to0.157; P .003) compared with those without pulmonary disease.
PAD patients with spinal stenosis had a greater average annual decline in 6-minute walk performance of77.4 ft/y (95%
CI,18.9 to35.8; P< .001) and usual-paced 4-meter walking velocity of0.045m/s/y (95% CI,0.081 to0.009;
P  .014) compared with participants without spinal stenosis.
Conclusion: At 3-year follow-up, pulmonary disease and spinal stenosis were each associated with a significant decline in
functioning among persons with PAD. In contrast, female sex and black race were not associated with functional decline
among persons with PAD. (J Vasc Surg 2005;42:1131–7.)Patients with lower-extremity peripheral arterial disease
(PAD) have greater functional impairment and more rapid
functional decline than patients without PAD.1,2 In per-
sons with PAD, a cross-sectional analyses shows female sex,
black race, and diabetes mellitus are associated with greater
functional impairment compared with male sex, white race,
and absence of diabetes mellitus, respectively.3-5 However,
relationships between these characteristics and other co-
morbid diseases with average annual functional decline are
unknown. Understanding clinical characteristics associated
with more rapid functional decline in persons with PAD
will aid physicians in the management of PAD patients,
allowing clinicians to better identify individuals who might
benefit from targeted interventions. Identifying the clinical
characteristics associated with increased rates of functional
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doi:10.1016/j.jvs.2005.08.010decline will also increase our understanding of the natural
history of PAD and may ultimately lead to new therapies to
slow functional decline in PAD patients.
We previously described associations between the ankle-
brachial index (ABI) and leg symptoms with functional
decline at 2-year follow-up in persons with and without
PAD.2 This prior report did not describe associations be-
tween gender, race, or comorbidities with functional de-
cline in PAD patients. The present study is limited to men
and women with PAD. We describe associations between
gender, black race, and comorbid diseases with average
annual decline in lower-extremity functioning in patients
with PAD at 3-year and 4-year follow-up. Based on previ-
ous cross-sectional analyses, we hypothesized that female
sex, black race, and diabetes mellitus would be associated
with greater functional decline than male sex, white race,
and absence of diabetes, respectively.3-5 We also aimed to
identify comorbid diseases consistently associated with de-
cline on our measures of lower extremity functioning.
METHODS
Methods for this longitudinal observational study of
men and women with and without PAD have been de-
scribed.2 The protocol was Institutional Review Board-
approved by Northwestern University and Catholic Health
Partners Hospital. All participants gave informed consent.
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identified consecutively from patients undergoing lower-
extremity arterial testing in three Chicago-area noninvasive
vascular laboratories. A small number of participants were
identified consecutively from patients with appointments in
a large general medicine practice at Northwestern who
were screened with the ABI. Participants attended a base-
line study visit between October 1998 and January 2000
and returned for annual follow-up for up to 4 years. Our a
priori study aims were identified for 3-year follow-up; how-
ever, we also assessed associations between variables of
interest and functional decline at 2-year and 4-year follow-
up. All participants were aged 55 at baseline. PAD was
defined as an ABI 0.90.6
Exclusion criteria. Exclusion criteria have been re-
ported.7 Patients with dementia, recent major surgery, or
foot or leg amputations were excluded. Nursing home
residents and wheelchair-bound patients were excluded.
Non-English-speaking patients were excluded because in-
vestigators were not fluent in non-English languages. Par-
ticipants who underwent lower-extremity revascularization
were excluded from analyses after the date of the revascu-
larization. Individuals with ethnic backgrounds other than
black and white were excluded because there were insuffi-
cient numbers of participants in these ethnic groups.
Ankle-brachial index measurement. Established meth-
ods were used to obtain systolic pressures in the right
brachial, right dorsalis pedis and posterior tibial arteries, left
dorsalis pedis and posterior tibial arteries, and left brachial
artery1,8 with a hand-held Doppler probe (Nicolet Vascular
Pocket Dop II, Golden, Colo). Each pressure was mea-
sured in the order listed and then in reverse order.
The ABI was calculated in each leg by dividing the
mean of all four dorsalis pedis and posterior tibial pressures
by the mean of the four brachial pressures.1,8 This method
of ABI calculation has been shown to correlate more closely
with lower-extremity functioning than alternative methods
of ABI calculation.8
Average brachial pressures in the arm with highest
pressure were used when one brachial pressure was higher
than the opposite brachial pressure in both measurement
sets and the two brachial pressures differed by10 mmHg
in at least one measurement set, because in such cases,
subclavian stenosis was possible.9 The lower of the right
and left ABI values was used in analyses.
Leg symptom groups. For PAD participants, leg
symptoms were classified into one of five groups using the
San Diego Claudication Questionnaire, based on previous
study.7,10 Four groups had exertional leg symptoms as
determined by an affirmative response to the question, “Do
you get pain in either leg or buttock on walking?” These
participants were further classified as follows based on their
responses to the San Diego Claudication Questionnaire:
1. intermittent claudication (IC)—exertional calf pain that
does not begin at rest, causes the participant to stop
walking, and resolves within ten minutes of rest;2. leg pain on exertion and rest—exertional leg pain that
sometimes begins at rest;
3. atypical exertional leg pain/carry on—exertional leg
symptoms that do not begin at rest and do not stop the
individual while walking;
4. atypical exertional leg pain/stop—exertional leg symp-
toms that do not begin at rest, stop the individual from
walking, and do not involve the calves or resolve within
ten minutes of rest.
A fifth group was defined as asymptomatic because they
reported no pain in either leg or buttock on walking.
Comorbidities. Algorithms developed for the Wom-
en’s Health and Aging Study (WHAS) were used to docu-
ment comorbidities.11,12 These algorithms combine data
from patient report, physical examination, medical record
review, medications, laboratory values, and a primary care
physician questionnaire. Comorbidities assessed usingWHAS
algorithmswere angina, diabetesmellitus, myocardial infarc-
tion, stroke, heart failure, pulmonary disease, spinal steno-
sis, and disk disease. American College of Rheumatology
criteria were used to diagnose knee osteoarthritis.13,14
Because of wide variation in prognosis and illness sever-
ity associated with various types of cancer, we did not
include cancer in our assessments of associations between
comorbidities and functional decline. Because of small
numbers of participants with documented hip osteoarthri-
tis, this comorbidity was also excluded from our analyses.
The specific algorithms used for comorbidity docu-
mentation with the WHAS algorithms are available on the
WHAS website.12 In general, the WHAS comorbidity al-
gorithms require the presence of at least two criteria to
Table I. Baseline characteristics of study participants
PAD (n  397)
Age (years)* 72.1  8.5
Female (%) 41.3
African American (%) 16.4
Ankle-brachial index 0.67  0.14
Body mass index (kg/m2) 27.44  5.0
Comorbidities
Diabetes (%) 30.0
Angina (%) 35.5
Congestive heart failure (%) 25.9
Myocardial infarction (%) 27.0
Stroke (%) 10.8
Disk disease (%) 30.7
Spinal stenosis (%) 11.1
Hip arthritis (%) 3.5
Knee arthritis (%) 10.8
Pulmonary disease (%) 32.0
6-min walk distance (feet)* 1128  387
4-m normal-paced walking velocity*† 0.881  0.21
4-m fast-paced walking velocity*† 1.202  0.28
Summary performance score
(0-12, 12  best)* 9.51  2.6
PAD, Peripheral arterial disease.
*Data expressed as  SD.
†Measure in meters/second.confirm the presence of each comorbidity. For each disease,
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nosis of the comorbidity and presence of the disease accord-
ing to a medical history questionnaire completed by the
primary care physician.
Other criteria for each comorbidity follow. For pulmo-
nary disease, additional criteria were abnormal pulmonary
function test results, symptoms consistent with pulmonary
disease, and use of pulmonary medications. Data used to
define the presence of angina included symptoms of angina
according to the Rose questionnaire, nitrate medication
use, and one of the following: abnormal stress test result,
abnormal coronary angiogram, or history of coronary ar-
tery revascularization. Criteria for the presence of myocar-
dial infarction were an electrocardiogram consistent with
an acute or old myocardial infarction and abnormal serum
levels of cardiac enzymes. For heart failure, criteria included
heart failure medications (diuretic use combined with dig-
italis or a vasodilator), symptoms of orthopnea, or an
echocardiogram consistent with heart failure. For disc dis-
ease, criteria included prior surgery, hospitalization, or
current treatment for disc disease. Similarly, for spinal
stenosis, criteria included prior surgery, hospitalization, or
current treatment for spinal stenosis. For stroke, additional
criteria were prior hospitalization for stroke, documented
by medical record review. Criteria for diabetes mellitus
were use of diabetes medication and a hemoglobinA1c value
Fig 1. Differences in average annual change in the 6-minute walk
and summary performance score over 3-year follow-up among 397
individuals with peripheral arterial disease according to the pres-
ence versus absence of baseline comorbidities.10%.Functional measures. Six-minute walk. The 6-minute
walk measures walking endurance and correlates with phys-
ical activity levels in patients with PAD.15 Following a
standardized protocol,16,17 participants walk up and down
a 100-foot hallway for 6 minutes after instructions to cover
as much distance as possible.
Repeated chair rises.This test measures leg strength and
balance.18,19 Participants sit in a straight-backed chair with
arms folded across their chest and stand five times consec-
utively as quickly as possible. Time to complete five chair
rises is measured.
Standing balance. Participants were asked to hold three
increasingly difficult standing positions for 10 seconds
each: standing with feet together side-by-side and parallel
(side-by-side stand), standing with feet parallel with the
toes of one foot adjacent to and touching the heel of the
opposite foot (semi-tandem stand), and standing with one
foot directly in front of the other.18,19
Four-meter walking velocity.Walking velocity was mea-
sured with a 4-meter walk performed at “usual” and “fast-
est” pace. Each walk was performed twice. The faster walk
in each pair was used in analyses.18,19
Summary performance score. The summary performance
score is a global measure of leg functioning that predicts
mobility loss, nursing home placement, and mortality
Fig 2. Differences in average annual change in the usual paced
and rapid paced 4-meter walking velocity over 3-year follow-up
among 397 individuals with peripheral arterial disease according to
the presence versus absence of baseline comorbidities.among community dwelling elderly.18,19 To calculate the
index
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performance on usual-pace 4-meter walking velocity, time
to rise from a seated position five times, and standing
balance, respectively. Individuals receive a 0 score for each
task they are unable to complete. One to four scores for
each task are assigned based upon quartiles of performance
for over 6000 participants in the Established Populations
for the Epidemiologic Study of the Elderly.18,19 Scores are
summed to obtain the summary performance score, rang-
ing from 0 to 12.
Other measures. Participants who reported walking
for exercise at least three times per week during the past
2 weeks were classified as current exercisers. Depressive
symptoms were measured annually using the Geriatric De-
pression Scale Short Form (GDS-S), a 15-item question-
naire assessing the number of depressive symptoms20
(range, 0 to 15; 15  worst). Body mass index (BMI) was
calculated as weight (kg)/height (m)2. Cigarette smoking
was assessed with patient report, measured in pack-years.
Educational status was assessed with self-report.
Follow-up. If a data collection form indicated that the
participant was unable to complete functional measures at
follow-up due to wheelchair-confinement, exhaustion, or
other significant symptom, the individual was classified as
too disabled to complete functional measures. The princi-
pal investigator (M. M. M.) made these decisions based on
the data collection forms, blinded to all other participant
characteristics. When no information was provided because
a participant refused to complete functional tests, those
who met at least two of the following criteria were consid-
ered too disabled to walk: (1) the participant reported
walking 5 blocks during the previous week, (2) the score
for repeated chair rises was 0 or 1, (3) the score for the
standing balance test was 0 or 1. The criteria were defined
Table II. Adjusted associations between baseline comorbi
follow-up in 397 persons with peripheral arterial disease
6-min walk distance (f
Model
Age 4.454 (6.240, 2.668)
White vs black 10.369 (24.80, 45.534)
Female vs male 3.963 (30.75, 22.824)
Myocardial infarction 13.74 (43.09, 15.612)
Angina 8.176 (36.01, 19.663)
Heart failure 22.76 (51.29, 5.777)
Stroke 0.760 (40.48, 42.003)
Diabetes 14.29 (42.86, 14.286)
Knee osteoarthritis 29.207 (10.69, 69.102)
Spinal stenosis 77.40 (118.9, 35.88)
Disc disease 4.531 (22.97, 32.027)
Pulmonary disease 34.02 (60.42, 7.631)
Results of mixed linear regression models. In eachmodel, the dependent vari
adjust for age, race, gender  baseline variables (comorbidities, body mass
prior year functioning and patterns of missing data.before data analyses.Individuals who refused functional testing at follow-up
and met two of these criteria were assigned the minimum
value for each test not completed. The minimum value for
each test was equivalent to the poorest performance among
those who completed testing at the corresponding visit.
Statistical analyses. In comparing change in func-
tioning (eg, 6-minute walk distance) across different pa-
tient groups (ie, with vs without a specific characteristic), a
longitudinal or repeated measures analysis of covariance
(ANCOVA) was carried out using the mixed-effects linear
regression analysis.21 Dependent variables for each analysis
were the successive annual differences in each functional
measure. For example, for the 6-minute walk, the depen-
dent variable for the 3-year follow-up analyses was defined
as the successive differences in 6-minute walk distances;
that is, the difference in distance from baseline to the first
follow-up visit (FV-1), the difference in distance from FV-1
to the second annual follow up visit (FV-2), and the differ-
ence in distance from FV-2 to the third annual follow-up
visit (FV-3). Fully adjusted analyses consisted of a repeated
measure ANCOVA adjusting for gender, age, race, comor-
bid diseases, educational status, cigarette smoking, leg
symptoms, exercise, BMI, ABI, and prior year functioning
carried out on these successive differences.
Covariates were selected either because they have been
demonstrated to be associated with functional decline or
because they were considered reasonably likely to be asso-
ciated with functional decline. Mixed-effects models are
used to account for the potential correlations among suc-
cessive annual differences in each functional measure of the
same participant.
Handling missing data.Under this initial mixed-effects
regression analysis, statistically valid inference is guaran-
teed, provided missing data caused by patient dropout are
s, gender, and race with functional decline over 3-year
Average annual change
Normal-pace 4-m walking velocity (m/s)
P Model P
.000 0.004 (0.006, 0.002) .000
.562 0.013 (0.018, 0.043) .413
.771 0.012 (0.035, 0.011) .309
.358 0.004 (0.021, 0.029) .765
.564 0.007 (0.031, 0.017) .556
.118 0.022 (0.046, 0.002) .073
.971 0.006 (0.029, 0.042) .724
.326 0.013 (0.037, 0.012) .315
.151 0.016 (0.019, 0.050) .368
.000 0.045 (0.081, 0.009) .014
.746 0.001 (0.023, 0.024) .947
.012 0.017 (0.039, 0.006) .148
ere the successive annual differences in the functional performance. Models
, educational status, cigarette smoking, depression score, leg symptoms) ditie
eet)
ables wunrelated to unobserved data; that is, any missing data are
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to this assumption that missing data are MAR, we repeated
the fully adjusted comparisons using a repeated measures
pattern-mixture ANCOVA model.22,23 In this model, pa-
tients may be classified into possible patterns of missing
data.
Because data were analyzed using successive differ-
ences, there were two observed patterns of missing differ-
ences in our analyses for analyses of 3-year follow-up data:
missing the successive differences from FV-2 to FV-3 only
and missing the successive differences from FV-2 to FV-3
and from FV-1 to FV-2. Corresponding patterns of missing
data were included in analyses of 2-year and 4-year follow-
up data. The different patterns of missing data were included
as different binary indicator covariates (centered about their
means). By including patterns of missing data in analyses as
centered covariates and averaging over these patterns using
adjusted least squares means, one can obtain an unbiased
estimate of the marginal means, adjusting for covariates. 23
RESULTS
Table I shows characteristics of the study population.
Among the 397 participants with PAD, 123 (31%) had classic
symptoms of intermittent claudication, and 77 (19%) were
asymptomatic.
Adjusting for confounders, the average annual decline
in 6-minute walk performance at 3-year follow-up among
the PAD participants was 41.5  218 feet. Average
annual decline in 6-minute walk performance increased
with increasing time since the baseline visit. Compared with
the decline in 6-minute walk performance between the
baseline and first annual follow-up visit, the decline in
6-minute walk performance was greater by 7.2 feet be-
tween FV-1 and FV-2 and greater by 37.7 feet between
FV-2 and FV-3.
At 2-year and 3-year follow-up, adjusting for age, ABI,
leg symptoms, smoking, education, BMI, exercise, depres-
Table II. Continued.
(95% confidence intervals)
Fast-pace 4-m walking velocity (m/s)
Model P
0.005 (0.006, 0.003) .000
0.023 (0.012, 0.058) .202
0.006 (0.033, 0.022) .686
0.011 (0.019, 0.040) .483
0.008 (0.036, 0.020) .587
0.022 (0.050, 0.006) .128
0.020 (0.021, 0.062) .339
0.002 (0.027, 0.031) .893
0.003 (0.038, 0.043) .895
0.036 (0.078, 0.006) .094
0.011 (0.038, 0.017) .443
0.028 (0.054, 0.001) .042sive symptoms, comorbidities, prior year functioning, andpatterns of missing data, we found no significant associa-
tions between female sex vs male or between white race vs
black race and functional decline for any outcome measure
among persons with PAD. At 4-year follow-up, female sex
was associated with increased functional decline on the
usual-paced 4-meter walk compared with male sex, but
results were only marginally statistically significant at
0.018 m/s/y (95% CI, 0.035 to 0.000, P  .052).
Among persons with PAD at 3-year followup, pulmo-
nary disease and spinal stenosis were each associated inde-
pendently with significant decline in two or more func-
tional outcomes, adjusting for known and potential
confounders of age, sex, race, ABI, leg symptoms, smoking,
education, BMI, exercise, depressive symptoms, comor-
bidities, prior year functioning, and patterns of missing data
(Table II). In these analyses, pulmonary disease was asso-
ciated independently with significantly increased average
annual decline in 6-minute walk performance, fast-paced
4-meter walking speed, and the summary performance
score (Figs 1 and 2). Spinal stenosis was associated inde-
pendently with significantly greater decline in the 6-minute
walk and usual-paced 4-meter walking velocity compared
with absence of spinal stenosis. Higher baseline ABI values
were associated independently with significantly less func-
tional decline in the 6-minute walk and summary perfor-
mance score (data not shown).
We also studied associations between comorbidities
and functional decline at 2-year and 4-year follow-up. At
2-year follow-up, pulmonary disease was associated inde-
pendently with decline in 6-minute walk (P  .002), fast
4-meter walking velocity (P  .002) and the summary
performance score (P  .001). Spinal stenosis was associ-
ated with significant decline in the 6-minute walk (P 
.034). No other significant, independent relationships were
noted between baseline comorbid disease and functional
decline at 2-year follow-up. At 4-year follow-up, there were
no significant, independent associations between pulmo-
Summary performance score (0-12 scale, 12  best)
Model P
0.033 (0.053, 0.012) .002
0.122 (0.521, 0.276) .547
0.067 (0.232, 0.365) .662
0.129 (0.205, 0.463) .448
0.047 (0.364, 0.270) .770
0.297 (0.618, 0.024) .070
0.084 (0.387, 0.556) .725
0.138 (0.188, 0.464) .406
0.008 (0.464, 0.447) .971
0.272 (0.743, 0.199) .257
0.143 (0.168, 0.454) .365
0.460 (0.762, 0.157) .003nary disease and functional decline. Spinal stenosis was
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walk performance of 62.12 ft/y compared with absence
of spinal stenosis (95% CI, 98.10 to 26.15; P  .001).
Diabetes mellitus was associated with significantly in-
creased decline of 0.242 U/y in the summary perfor-
mance score compared to absence of diabetes mellitus (95%
CI, 0.446 to 0.038; P  .020). There were no other
significant associations between comorbid diseases and
functional decline at the 4-year follow-up.
DISCUSSION
We previously described associations between the ABI
and leg symptoms with functional decline at 2-year follow-up
in persons with and without PAD.2 In contrast to our
previously published work, in this report we determined
whether female sex vs male sex and black race vs white race
were associated with more rapid functional decline in per-
sons with PAD. In this study, we also aimed to identify
comorbidities associated with more rapid functional de-
cline in PAD. In 397 men and women with PAD followed
for a median of 3 years, pulmonary disease and spinal
stenosis were each associated with significantly increased
decline on two or more objective measures of lower-
extremity functioning compared with the absence of these
conditions, adjusting for known and potential confound-
ers. Associations between pulmonary disease and functional
decline were independent of cigarette smoking history.
Nearly one third of PAD patients in this study had
documented pulmonary disease. Previous study suggests
that pulmonary disease is often unrecognized in older
patients.24 If many PAD participants in this study had
unrecognized pulmonary disease, results reported here may
underestimate the magnitude of functional decline associ-
ated with pulmonary disease. Our findings suggest that
clinicians should assess PAD patients carefully for signs and
symptoms of pulmonary disease. PAD patients with pulmo-
nary disease should be considered at increased risk of
functional decline. Further study is needed to determine
whether exercise and other treatments, including treatment
of pulmonary disease, slow the rate of functional decline in
PAD patients with pulmonary disease. Further study is also
needed to determine whether treating spinal stenosis in
PAD patients improves functional decline.
At both 2-year and 3-year follow-up, we observed
significant associations between pulmonary disease and
functional decline in three of four functional outcomes
studied.However, we observed no significant, independent
associations between pulmonary disease and decline in
lower-extremity functioning at 4-year follow-up. Thus, in
persons with PAD, pulmonary disease was associated with
significant functional decline over 2-year and 3-year follow-up
but not longer-term follow-up. This may be partly due to a
phenomenon in which greater drop-out or mortality
among PAD patients with pulmonary disease after 3 years
diluted associations with functional decline in this subset of
persons with PAD. It is also important to point out that
compared with the annual decline in 6-minute walk perfor-
mance between baseline and FV-1, the adjusted averagedecline in 6-minute walk performance was greater by 7.2
feet between FV-1 and FV-2 and greater by 37.7 feet
between FV-2 and FV-3. Changes in rates of functional
decline over time in the cohort may also have influenced
our findings at three-year follow-up.
Although previous cross-sectional studies of persons
with PAD showed that female sex and black race were
associated with greater functional impairment than absence
of these conditions,3-5 we found no significant associations
between these characteristics and functional decline. PAD
participants in the present study had established PAD at the
time of study enrollment. Data reported here combined
with our cross-sectional findings3-5 suggest that black race
and female sex may contribute to functional impairment for
patients with early PAD or subclinical PAD. However, for
patients with established PAD, these characteristics are not
associated with more rapid functional decline. Our findings
regarding race and functional decline are of particular in-
terest, given that prior studies demonstrate reduced rates of
lower-extremity revascularization among blacks compared
with whites.25-28 Our results suggest that racial differences
in functional decline rates are unlikely to account for pre-
viously demonstrated reduced rates of revascularization in
blacks compared with whites.
Our study has limitations. PAD participants in our
cohort had established PAD. Our findings may not be
generalizable to PAD patients with mild or subclinical
disease. Second, our study included analyses of associations
between multiple characteristics and functional decline. It
is conceivable that some associations may have been statis-
tically significant by chance. However, pulmonary disease
and spinal stenosis were each associated with functional
decline in two or more functional outcome measures at
2-year and 3-year follow-up, reducing the possibility that
these associations were statistically significant by chance.
Third, comorbid disease was not classified according to
severity. Fourth, treatment of comorbid diseases was not
considered in our statistical analyses. Finally, associations
between pulmonary disease and functional decline reported
here are likely to be influenced by higher mortality and/or
drop-out rates among participants with pulmonary disease.
This phenomenon may have resulted in the lack of signifi-
cant associations between pulmonary disease and func-
tional decline at 4-year follow-up.
CONCLUSION
Our findings reported here demonstrate that men and
women with PAD experience functional decline at compa-
rable rates. Similarly, blacks and whites with PAD have
similar rates of functional decline. Among patients with
PAD, the presence of pulmonary disease or spinal stenosis
predicts significantly increased rates of functional decline
compared with absence of these conditions at 3-year follow-
up. Our data suggest that clinicians should evaluate PAD
patients carefully for co-existent pulmonary disease. Fur-
ther study is needed to determine whether targeted inter-
ventions can improve functioning or prevent decline in
JOURNAL OF VASCULAR SURGERY
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